Skip to main content
TipRanks
Go Ultimate75% OFF

Vir Biotechnology (VIR) Ratios

1,581 Followers

Vir Biotechnology Ratios

VIR's free cash flow for Q3 2026 was $-106.11M. For the 2026 fiscal year, VIR's free cash flow was decreased by $-34.00K and operating cash flow was $-106.08M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio5.548.719.054.934.58
Quick Ratio5.548.719.054.934.58
Cash Ratio2.521.861.381.661.02
Solvency Ratio-1.79-2.04-1.810.721.02
Operating Cash Flow Ratio-4.22-3.73-4.443.25-0.14
Short-Term Operating Cash Flow Coverage-44.530.000.000.000.00
Net Current Asset Value$ 276.53M$ 794.03M$ 1.26B$ 1.79B$ 1.04B
Leverage Ratios
Debt-to-Assets Ratio0.190.070.060.050.07
Debt-to-Equity Ratio0.240.090.080.060.10
Debt-to-Capital Ratio0.200.080.070.060.09
Long-Term Debt-to-Capital Ratio0.100.000.000.000.00
Financial Leverage Ratio1.311.221.211.351.36
Debt Service Coverage Ratio-51.890.000.000.000.00
Interest Coverage Ratio0.000.000.000.000.00
Debt to Market Cap0.120.000.000.000.00
Interest Debt Per Share1.350.720.930.971.06
Net Debt to EBITDA0.100.250.18-0.86-0.49
Profitability Margins
Gross Profit Margin82.92%-545.03%-564.69%61.57%53.09%
EBIT Margin-682.68%-705.44%-767.10%51.56%38.41%
EBITDA Margin-665.65%-685.82%-744.53%51.98%38.94%
Operating Profit Margin-682.68%-791.27%-794.04%51.56%38.41%
Pretax Profit Margin-638.56%-704.95%-728.93%46.68%50.19%
Net Profit Margin-638.87%-703.40%-713.69%31.92%48.25%
Continuous Operations Profit Margin-638.87%-703.40%-713.76%31.92%48.25%
Net Income Per EBT100.05%99.78%97.91%68.39%96.14%
EBT Per EBIT93.54%89.09%91.80%90.54%130.67%
Return on Assets (ROA)-43.68%-37.31%-32.05%18.41%27.05%
Return on Equity (ROE)-57.23%-45.37%-38.68%24.82%36.92%
Return on Capital Employed (ROCE)-51.43%-45.90%-39.25%36.36%26.08%
Return on Invested Capital (ROIC)-50.94%-45.53%-38.15%24.82%25.02%
Return on Tangible Assets-44.78%-37.99%-32.72%18.74%27.76%
Earnings Yield-52.44%-52.19%-45.58%15.37%9.72%
Efficiency Ratios
Receivables Turnover19.040.000.000.001.42
Payables Turnover1.1994.2090.4496.6978.80
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.580.600.528.598.42
Asset Turnover0.070.050.040.580.56
Working Capital Turnover Ratio0.100.060.051.001.16
Cash Conversion Cycle-286.50-3.87-4.04-3.77252.96
Days of Sales Outstanding19.170.000.000.00257.60
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding305.663.874.043.774.63
Operating Cycle19.170.000.000.00257.60
Cash Flow Ratios
Operating Cash Flow Per Share-2.83-3.28-5.8112.54-0.37
Free Cash Flow Per Share-2.86-3.33-5.9712.03-0.53
Dividend Paid and CapEx Coverage Ratio-81.08-61.14-36.1024.46-2.18
Capital Expenditure Coverage Ratio-81.08-61.14-36.1024.46-2.18
Operating Cash Flow Coverage Ratio-2.10-4.56-6.2513.00-0.35
Operating Cash Flow to Sales Ratio-5.71-6.02-9.041.03-0.04
Free Cash Flow Yield-47.48%-45.36%-59.31%47.53%-1.28%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-1.91-1.92-2.196.5110.29
Price-to-Sales (P/S) Ratio12.1813.4815.662.084.96
Price-to-Book (P/B) Ratio1.090.870.851.623.80
Price-to-Free Cash Flow (P/FCF) Ratio-2.11-2.20-1.692.10-78.35
Price-to-Operating Cash Flow Ratio-2.13-2.24-1.732.02-114.28
Price-to-Earnings Growth (PEG) Ratio0.110.120.01-1.47-0.04
Enterprise Value Multiple-1.73-1.72-1.923.1412.26
Enterprise Value788.08M875.00M1.23B2.64B5.23B
EV to EBITDA-1.73-1.72-1.923.1412.26
EV to Sales11.5011.7914.301.634.77
EV to Free Cash Flow-1.99-1.93-1.541.65-75.32
EV to Operating Cash Flow-2.01-1.96-1.581.58-109.86
Tangible Book Value Per Share5.358.2611.5615.3010.64
Shareholders’ Equity Per Share5.528.4411.8615.6711.02
Tax and Other Ratios
Effective Tax Rate-0.000.000.020.320.04
Revenue Per Share0.490.540.6412.188.43
Net Income Per Share-3.16-3.83-4.593.894.07
Tax Burden1.001.000.980.680.96
Interest Burden0.941.000.950.911.31
Research & Development to Revenue6.316.836.730.290.41
SG&A to Revenue1.340.000.000.000.00
Stock-Based Compensation to Revenue0.721.060.000.060.08
Income Quality0.890.861.273.22-0.09

Currency in USD